{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:41:21Z","timestamp":1792597281154,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Understanding more about the risk of cardiovascular disease in the large population-group with mild Covid-19 is essential since the preventive need might be extensive. This study examined the risk of cardiovascular disease following Covid-19, considering risk periods and prognostic factors i.e., social factors, Covid-19-vaccination and comorbidities. The study cohort included the Swedish population aged 40-75 years (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20094,095,414). Covid-19 was associated with elevated hazard ratios for all outcomes; ranging from 1.22 (95% confidence interval:1.14-1.31) for acute myocardial infarction to 4.31 (95% confidence interval:4.09-4.55) for pulmonary embolism. The increased risk was most evident among hospitalised individuals, however, also individuals with mild Covid-19 had an elevated risk. Finally, our findings demonstrated increased long-term cardiovascular risk and generally stronger effects of Covid-19 in more vulnerable social groups. In this work, we demonstrate an increased risk of cardiovascular disease after Covid-19, also among mild cases, findings relevant from both a public health and healthcare perspective.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-66270-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:16:10Z","timestamp":1763471770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Covid-19 and cardiovascular disease in a total population-study of long-term effects, social factors and Covid-19-vaccination"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1754-6531","authenticated-orcid":false,"given":"Malin","family":"Spetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Natt och Dag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-0829","authenticated-orcid":false,"given":"Huiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0892-5668","authenticated-orcid":false,"given":"Fredrik","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rosvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"66270_CR1","unstructured":"WHO COVID-19 Dashboard. https:\/\/covid19.who.int\/ (2024)."},{"key":"66270_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/00325481.2020.1823094","volume":"133","author":"G White-Dzuro","year":"2021","unstructured":"White-Dzuro, G. et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgrad. Med 133, 20\u201327 (2021).","journal-title":"Postgrad. Med"},{"key":"66270_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B. & Wu, J. C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 17, 543\u2013558 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"66270_CR4","unstructured":"World Health Organization, Cardiovascular diseases (CVDs). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) (2025)."},{"key":"66270_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/v15020508","volume":"15","author":"I Vosko","year":"2023","unstructured":"Vosko, I., Zirlik, A. & Bugger, H. Impact of COVID-19 on cardiovascular disease. Viruses 15, 508 (2023).","journal-title":"Viruses"},{"key":"66270_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11239-020-02228-y","volume":"50","author":"YK Tan","year":"2020","unstructured":"Tan, Y. K. et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J. Thromb. Thrombolysis 50, 587\u2013595 (2020).","journal-title":"J. Thromb. Thrombolysis"},{"key":"66270_CR7","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","volume":"142","author":"D Modin","year":"2020","unstructured":"Modin, D. et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation 142, 2080\u20132082 (2020).","journal-title":"Circulation"},{"key":"66270_CR8","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jacc.2021.03.006","volume":"77","author":"J Alvarez-Garcia","year":"2021","unstructured":"Alvarez-Garcia, J. et al. New heart failure diagnoses among patients hospitalized for COVID-19. J. Am. Coll. Cardiol. 77, 2260\u20132262 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"66270_CR9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.122.060785","volume":"146","author":"R Knight","year":"2022","unstructured":"Knight, R. et al. CVD-COVID-UK\/COVID-IMPACT consortium and the longitudinal health and wellbeing COVID-19 National Core Study. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and wales. Circulation 146, 892\u2013906 (2022). Sep 20.","journal-title":"Circulation"},{"key":"66270_CR10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1161\/ATVBAHA.124.321001","volume":"44","author":"JR Hilser","year":"2024","unstructured":"Hilser, J. R. et al. COVID-19 is a coronary artery disease risk equivalent and exhibits a genetic interaction with ABO blood type. Arterioscler Thromb. Vasc. Biol. 44, 2321\u20132333 (2024).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"66270_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88111-z","volume":"11","author":"S Tsai","year":"2021","unstructured":"Tsai, S. et al. COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans. Sci. Rep. 11, 8497 (2021).","journal-title":"Sci. Rep."},{"key":"66270_CR12","doi-asserted-by":"publisher","first-page":"n1098","DOI":"10.1136\/bmj.n1098","volume":"373","author":"SE Daugherty","year":"2021","unstructured":"Daugherty, S. E. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 373, n1098 (2021).","journal-title":"BMJ"},{"key":"66270_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","volume":"398","author":"I Katsoularis","year":"2021","unstructured":"Katsoularis, I., Fonseca-Rodr\u00edguez, O., Farrington, P., Lindmark, K. & Fors Connolly, A. M. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 398, 599\u2013607 (2021).","journal-title":"Lancet"},{"key":"66270_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/heartjnl-2022-321492","volume":"109","author":"Z Raisi-Estabragh","year":"2022","unstructured":"Raisi-Estabragh, Z. et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart 109, 119\u2013126 (2022).","journal-title":"Heart"},{"key":"66270_CR15","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/cvr\/cvac195","volume":"119","author":"EYF Wan","year":"2023","unstructured":"Wan, E. Y. F. et al. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank. Cardiovasc. Res. 119, 1718\u20131727 (2023).","journal-title":"Cardiovasc. Res."},{"key":"66270_CR16","doi-asserted-by":"publisher","first-page":"e069590","DOI":"10.1136\/bmj-2021-069590","volume":"377","author":"I Katsoularis","year":"2022","unstructured":"Katsoularis, I. et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 377, e069590 (2022).","journal-title":"BMJ"},{"key":"66270_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med 28, 583\u2013590 (2022).","journal-title":"Nat. Med"},{"key":"66270_CR18","doi-asserted-by":"publisher","first-page":"oead120","DOI":"10.1093\/ehjopen\/oead120","volume":"3","author":"I Katsoularis","year":"2023","unstructured":"Katsoularis, I. et al. Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study. Eur. Heart J. Open 3, oead120 (2023).","journal-title":"Eur. Heart J. Open"},{"key":"66270_CR19","doi-asserted-by":"publisher","first-page":"e083171","DOI":"10.1136\/bmjopen-2023-083171","volume":"14","author":"C Schade Skov","year":"2024","unstructured":"Schade Skov, C., Potteg\u00e5rd, A., Harbo Andersen, J., Andersen, G. & Lassen, A. T. Short-term and long-term stroke risk following SARS-CoV-2 infection in relation to disease severity: a Danish national cohort study. BMJ Open 14, e083171 (2024).","journal-title":"BMJ Open"},{"key":"66270_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamainternmed.2022.3858","volume":"182","author":"J Xie","year":"2022","unstructured":"Xie, J. et al. Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. JAMA Intern Med 182, 1063\u20131070 (2022).","journal-title":"JAMA Intern Med"},{"key":"66270_CR21","doi-asserted-by":"publisher","first-page":"oead101","DOI":"10.1093\/ehjopen\/oead101","volume":"3","author":"HM la Roi-Teeuw","year":"2023","unstructured":"la Roi-Teeuw, H. M. et al. Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study. Eur. Heart J. Open 3, oead101 (2023).","journal-title":"Eur. Heart J. Open"},{"key":"66270_CR22","doi-asserted-by":"publisher","first-page":"100284","DOI":"10.1016\/j.rpth.2023.100284","volume":"7","author":"H Sjoland","year":"2023","unstructured":"Sjoland, H. et al. Pulmonary embolism and deep venous thrombosis after COVID-19: long-term risk in a population-based cohort study. Res Pr. Thromb. Haemost. 7, 100284 (2023).","journal-title":"Res Pr. Thromb. Haemost."},{"key":"66270_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s11886-023-01950-2","volume":"25","author":"MP Fundora","year":"2023","unstructured":"Fundora, M. P., Kamidani, S. & Oster, M. E. COVID vaccination as a strategy for cardiovascular disease prevention. Curr. Cardiol. Rep. 25, 1327\u20131335 (2023).","journal-title":"Curr. Cardiol. Rep."},{"key":"66270_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29521-z","volume":"13","author":"M Whitaker","year":"2022","unstructured":"Whitaker, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13, 1957 (2022).","journal-title":"Nat. Commun."},{"key":"66270_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/eurpub\/ckad191","volume":"34","author":"M Spetz","year":"2024","unstructured":"Spetz, M. et al. The sociodemographic patterning of sick leave and determinants of longer sick leave after mild and severe COVID-19: a nationwide register-based study in Sweden. Eur. J. Public Health 34, 121\u2013128 (2024).","journal-title":"Eur. J. Public Health"},{"key":"66270_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/eurheartj\/ehae639","volume":"46","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study. Eur. Heart J. 46, 147\u2013157 (2025).","journal-title":"Eur. Heart J."},{"key":"66270_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson, J. F., Otterblad-Olausson, P., Pettersson, B. U. & Ekbom, A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur. J. Epidemiol. 24, 659\u2013667 (2009).","journal-title":"Eur. J. Epidemiol."},{"key":"66270_CR28","unstructured":"Folkh\u00e4lsomyndigheten [The Public Health Agency of Sweden], Veckorapport om covid-19, vecka 19, [Weekly report on Covid-19, week 19]. https:\/\/www.folkhalsomyndigheten.se\/globalassets\/statistik-uppfoljning\/smittsamma-sjukdomar\/veckorapporter-covid-19\/2022\/veckorapport-for-covid-19-vecka-19-2022.pdf (2022)."},{"key":"66270_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2147\/CLEP.S312742","volume":"13","author":"F Nyberg","year":"2021","unstructured":"Nyberg, F. et al. Swedish Covid-19 investigation for future insights - a population epidemiology approach using register linkage (SCIFI-PEARL). Clin. Epidemiol. 13, 649\u2013659 (2021).","journal-title":"Clin. Epidemiol."},{"key":"66270_CR30","doi-asserted-by":"publisher","first-page":"e029971","DOI":"10.1161\/JAHA.123.029971","volume":"12","author":"C Krittanawong","year":"2023","unstructured":"Krittanawong, C., Khawaja, M., Tamis-Holland, J. E., Girotra, S. & Rao, S. V. Acute myocardial infarction: etiologies and mimickers in young patients. J. Am. Heart Assoc. 12, e029971 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"66270_CR31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/heartjnl-2019-316067","volume":"106","author":"J Jortveit","year":"2020","unstructured":"Jortveit, J., Pripp, A. H., Lang\u00f8rgen, J. & Halvorsen, S. Incidence, risk factors and outcome of young patients with myocardial infarction. Heart 106, 1420\u20131426 (2020).","journal-title":"Heart"},{"key":"66270_CR32","doi-asserted-by":"publisher","first-page":"e2444","DOI":"10.1212\/WNL.0000000000007533","volume":"92","author":"MS Ekker","year":"2019","unstructured":"Ekker, M. S. et al. Stroke incidence in young adults according to age, subtype, sex, and time trends. Neurology 92, e2444\u2013e2454 (2019).","journal-title":"Neurology"},{"key":"66270_CR33","unstructured":"Statens offentliga utredningar [Sweden Government Official Reports] \u00c4ldreomsorgen under pandemin, Delbet\u00e4nkande av Coronakommissionen, [Elder care during the pandemic: Interim report by the Corona Commission], SOU 80, (2020)."},{"key":"66270_CR34","unstructured":"Folkh\u00e4lsomyndigheten [The Public Health Agency of Sweden], Plan f\u00f6r eventuella r\u00e5d, rekommendationer och smittskydds\u00e5tg\u00e4rder mot Covid-19, Regeringens uppdrag S2022\/02127 [Plan for potential advice, recommendations and infection control measures, Government assignment S2022\/02127] (2022)."},{"key":"66270_CR35","unstructured":"The World Bank. World Bank Country and Lending Groups. World Bank Country and Lending Groups \u2013 World Bank Data Help Desk. https:\/\/datahelpdesk.world bank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups (May 2024)."},{"key":"66270_CR36","unstructured":"Statistiska Centralbyr\u00e5n (SCB) [Statistics Sweden], Anv\u00e4ndbara variabler i LISA-databasen, 2021-03-26, [Useful variables in the LISA database, 2021-03-26], (2021)."},{"key":"66270_CR37","doi-asserted-by":"crossref","unstructured":"Kleinbaum D. G., Klein M. Survival Analysis: A Self-learning Text. (Springer, New York, 2012).","DOI":"10.1007\/978-1-4419-6646-9"},{"key":"66270_CR38","unstructured":"Socialstyrelsen [The National Board of Health and Welfare]. F\u00f6ljsamheten till nationella riktlinjer under Covid-19-pandemin [Compliance to national recommendations during the Covid-19-pandemic], Article number 2022-11-8247 (2022)."},{"key":"66270_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-025-01531-5","volume":"83","author":"A Hallberg","year":"2025","unstructured":"Hallberg, A. et al. Epidemiological outcomes and policy implementation in the Nordic countries during the COVID-19 pandemic. Arch. Public Health 83, 46 (2025).","journal-title":"Arch. Public Health"},{"key":"66270_CR40","doi-asserted-by":"publisher","first-page":"e2324246","DOI":"10.1001\/jamanetworkopen.2023.24246","volume":"6","author":"M Bygdell","year":"2023","unstructured":"Bygdell, M., Kindblom, J. M., Martikainen, J., Li, H. & Nyberg, F. Incidence and Characteristics in Children with Post-COVID-19 Condition in Sweden. JAMA Netw. Open 6, e2324246 (2023).","journal-title":"JAMA Netw. Open"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66270-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66270-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66270-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:02:42Z","timestamp":1763863362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66270-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66270"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66270-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Dr. Nyberg reports ownership of some Astra Zeneca shares. Dr. Nyberg and Dr. Li report participation in a research projects funded by Bayer and AstraZeneca (regulator-mandated phase IV study; investigator-initiated study), with funds paid to the University of Gothenburg where they are employed (no personal fees)\u00a0and with no relation to the work reported here. M. Spetz, Dr. Natt och Dag and Dr. Rosvall have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10115"}}